Elagolix
Elagolix
Elagolix (pronounced as /ɛləˈɡɒlɪks/) is a gonadotropin-releasing hormone antagonist (GnRH antagonist) used for the treatment of endometriosis and uterine fibroids.
Etymology
The term "Elagolix" is derived from the chemical structure of the drug. The prefix "Ela-" is derived from the chemical element Elaeagnus, and "-golix" is a common suffix used in the naming of GnRH antagonists.
Usage
Elagolix is used primarily for the treatment of pain associated with endometriosis and heavy menstrual bleeding caused by uterine fibroids in premenopausal women. It works by decreasing the production of certain hormones in the body.
Side Effects
Common side effects of Elagolix include hot flashes, headache, nausea, insomnia, and depression. Serious side effects may include bone loss and changes in menstrual periods.
Related Terms
See Also
- List of GnRH Antagonists
- List of Drugs Used for Endometriosis
- List of Drugs Used for Uterine Fibroids
External links
- Medical encyclopedia article on Elagolix
- Wikipedia's article - Elagolix
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski